Why Gritstone Oncology Is Bolting Higher Today

Why Gritstone Oncology Is Bolting Higher Today

What happened Shares of the clinical-stage biotech Gritstone Oncology (NASDAQ: GRTS) rose by as much as 44% in pre-market trading Tuesday morning. The drugmaker's stock is heating up today in response to an agreement with the National Institute of Allergy and Infectious Diseases (NIAID) to initiate a phase 1 trial of its second-generation SARS-CoV-2 vaccine candidate.